FNY Investment Advisers »

Nektar Therapeutics shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-06-30 $39k 1.5k 25.57

More positions owned by FNY Investment Advisers

Blueprint Medicines (BPMC)
Vodafone Group Adr Rep 10 Ord Sponsored Adr (VOD)
Ericsson Spon Adr Rep 1 Cl B Ord Sponsored Adr (ERIC)
Codere Online Luxembourg Ord (CDRO)
NVIDIA Corporation (NVDA)
Kellogg Company (K)
Juniper Networks (JNPR)
Cohen Circle Acquisition Cor (CCIR)
Ansys (ANSS)
Doordash (DASH)
Enstar Group (ESGR)
Facebook Inc cl a (META)
Uber Technologies (UBER)
Broadcom (AVGO)
British American Tobacco Adr Rep Ord Sponsored Adr (BTI)

View all positions for FNY Investment Advisers

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics